• Describe emerging HIV prevention and treatment strategies, including long-acting antiretroviral therapies, broadly neutralizing antibodies, and novel agents in clinical development, and discuss their potential role in advancing HIV care.
  • Evaluate the clinical evidence supporting new HIV therapeutic and prevention approaches, including their efficacy, safety, adherence advantages, and potential limitations compared with current standards of care.
  • Identify implementation opportunities and challenges associated with integrating emerging HIV therapies into clinical practice, with particular attention to improving access, retention in care, and health equity among underserved populations.
Session date: 
08/20/2026 - 8:00am to 9:00am CDT
Location: 
UT Southwestern Medical Center (Hybrid)
5323 Harry Hines Blvd
Dallas, TX 75390
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA
  • 1.00 Ethics
Please login or create an account to take this course.